The European Union has given the green light to a drug which doubles the survival rates for people with myeloma. The drug Revlimid (lenalidomide) comes in the form of a pill and has been given approval by the European Medicines Agency (EMEA) for use in combination with a standard therapy called dexamethasone... 

Multiple myeloma is a cancer of your plasma cells. Plasma cells are a type of white blood cell present in your bone marrow. In multiple myeloma, a group of abnormal plasma cells (myeloma cells) multiplies, raising the number of plasma cells to a more than normal level. The result can be erosion of... 

Definition Multiple myeloma is a cancer of the plasma cells in bone marrow. Alternative Names Plasma cell dyscrasia; Plasma cell myeloma; Malignant plasmacytoma; Plasmacytoma of bone; Myeloma - multiple Causes, incidence, and risk factors Plasma cells help the body’s immune system fight disease.... 

The presence of unexplained [[anemia]], [[kidney]] dysfunction, a high [[erythrocyte sedimentation rate]] (ESR) and a high serum [[protein]] (especially raised [[immunoglobulin]]) may prompt further testing. A [[medical doctor|doctor]] will request [[protein electrophoresis]] of the blood and urine,... 

Multiple myeloma is cancer that begins in plasma cells, a type of white blood cell. To understand multiple myeloma, it is helpful to know about normal blood cells. Normal blood cells Most blood cells develop from cells in the bone marrow called stem cells. Bone marrow is the soft material in the center... 

Myeloma-Osteoclast Interactions as a Model Shmuel Yaccoby, Michele J. Wezeman, Aminah Henderson, Michele Cottler-Fox, Qing Yi, Bart Barlogie and Joshua Epstein Myeloma Institute for Research and Therapy, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas... 

Multiple myeloma is the most common primary neoplasm of the skeletal system. The disease is a malignancy of plasma cells. Radiologically, multiple destructive lesions of the skeleton as well as severe demineralization characterize multiple myeloma. The etiology of the disease is the monoclonal proliferation... 

How it began In 1998, Geraldine Ferraro made a bid for a seat in the United States Senate, but lost. That December, when she went for her annual physical, her doctor noticed something irregular in her white blood cell count. Testing showed she was in the early stages of plasma cell cancer. “When... 

Also called: Plasma-cell myeloma Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid... 

This National Cancer Institute (NCI) booklet (NIH Publication No. 05-1575) has important information about multiple myeloma*, cancer that starts in certain white blood cells (plasma cells). You will read about possible causes, symptoms, diagnosis, treatment, and supportive care. You also will find ideas...